Literature DB >> 24106171

A high-yielding CHO transient system: coexpression of genes encoding EBNA-1 and GS enhances transient protein expression.

Olalekan Daramola1, Jessica Stevenson, Greg Dean, Diane Hatton, Gary Pettman, William Holmes, Ray Field.   

Abstract

An efficient rapid protein expression system is crucial to support early drug development. Transient gene expression is an effective route, and to facilitate the use of the same host cells as for subsequent stable cell line development, we have created a high-yielding Chinese hamster ovary (CHO) transient expression system. Suspension-adapted CHO-K1 host cells were engineered to express the gene encoding Epstein-Barr virus (EBV) nuclear antigen-1 (EBNA-1) with and without the coexpression of the gene for glutamine synthetase (GS). Analysis of the transfectants indicated that coexpression of EBNA-1 and GS enhanced transient expression of a recombinant antibody from a plasmid carrying an OriP DNA element compared to EBNA-1-only transfectants. This was confirmed with the retransfection of an EBNA-1-only cell line with a GS gene. The retransfected cell lines showed an increase in transient expression when compared with that of the EBNA-1-only parent. The transient expression process for the best CHO transient cell line was further developed to enhance protein expression and improve scalability by optimizing the transfection conditions and the cell culture process. This resulted in a scalable CHO transient expression system that is capable of expressing 2 g/L of recombinant proteins such as antibodies. This system can now rapidly provide gram amounts of recombinant antibody to supply preclinical development studies that has comparable product quality to antibody produced from a stably transfected CHO cell line.
© 2013 American Institute of Chemical Engineers.

Entities:  

Keywords:  CHO cells; EBNA-1; glutamine synthetase; polyethylenimine; transient gene expression

Mesh:

Substances:

Year:  2013        PMID: 24106171     DOI: 10.1002/btpr.1809

Source DB:  PubMed          Journal:  Biotechnol Prog        ISSN: 1520-6033


  31 in total

1.  Immunization with Low Doses of Recombinant Postfusion or Prefusion Respiratory Syncytial Virus F Primes for Vaccine-Enhanced Disease in the Cotton Rat Model Independently of the Presence of a Th1-Biasing (GLA-SE) or Th2-Biasing (Alum) Adjuvant.

Authors:  Kirsten Schneider-Ohrum; Corinne Cayatte; Angie Snell Bennett; Gaurav Manohar Rajani; Patrick McTamney; Krystal Nacel; Leigh Hostetler; Lily Cheng; Kuishu Ren; Terrence O'Day; Gregory A Prince; Michael P McCarthy
Journal:  J Virol       Date:  2017-03-29       Impact factor: 5.103

2.  A peptide derived from melanotransferrin delivers a protein-based interleukin 1 receptor antagonist across the BBB and ameliorates neuropathic pain in a preclinical model.

Authors:  George Thom; Mei-Mei Tian; Jon P Hatcher; Natalia Rodrigo; Matthew Burrell; Ian Gurrell; Timothy Z Vitalis; Thomas Abraham; Wilfred A Jefferies; Carl I Webster; Reinhard Gabathuler
Journal:  J Cereb Blood Flow Metab       Date:  2018-05-30       Impact factor: 6.200

3.  A simple, rapid method for evaluation of transfection efficiency based on fluorescent dye.

Authors:  Lin Peng; Wendian Xiong; Yanfei Cai; Yun Chen; Yang He; Jianfeng Yang; Jian Jin; Huazhong Li
Journal:  Bioengineered       Date:  2016-09-27       Impact factor: 3.269

4.  Structural and functional characterization of a specific antidote for ticagrelor.

Authors:  Andrew Buchanan; Philip Newton; Susanne Pehrsson; Tord Inghardt; Thomas Antonsson; Peder Svensson; Tove Sjögren; Linda Öster; Annika Janefeldt; Ann-Sofie Sandinge; Feenagh Keyes; Mark Austin; Jennifer Spooner; Peter Gennemark; Mark Penney; Garnet Howells; Tristan Vaughan; Sven Nylander
Journal:  Blood       Date:  2015-03-18       Impact factor: 22.113

5.  A conserved immunogenic and vulnerable site on the coronavirus spike protein delineated by cross-reactive monoclonal antibodies.

Authors:  Chunyan Wang; Rien van Haperen; Javier Gutiérrez-Álvarez; Wentao Li; Nisreen M A Okba; Irina Albulescu; Ivy Widjaja; Brenda van Dieren; Raul Fernandez-Delgado; Isabel Sola; Daniel L Hurdiss; Olalekan Daramola; Frank Grosveld; Frank J M van Kuppeveld; Bart L Haagmans; Luis Enjuanes; Dubravka Drabek; Berend-Jan Bosch
Journal:  Nat Commun       Date:  2021-03-17       Impact factor: 14.919

Review 6.  Non-conventional expression systems for the production of vaccine proteins and immunotherapeutic molecules.

Authors:  Isabelle Legastelois; Sophie Buffin; Isabelle Peubez; Charlotte Mignon; Régis Sodoyer; Bettina Werle
Journal:  Hum Vaccin Immunother       Date:  2016-12-01       Impact factor: 3.452

7.  The TGF-β inhibitory activity of antibody 37E1B5 depends on its H-CDR2 glycan.

Authors:  Ping Tsui; Daniel R Higazi; Yanli Wu; Rebecca Dunmore; Emilie Solier; Toyin Kasali; Nicholas J Bond; Catherine Huntington; Alan Carruthers; John Hood; M Jack Borrok; Arnita Barnes; Keith Rickert; Sandrina Phipps; Lena Shirinian; Jie Zhu; Michael A Bowen; William Dall'Acqua; Lynne A Murray
Journal:  MAbs       Date:  2016-11-11       Impact factor: 5.857

8.  Mechanistic insights into the rational design of masked antibodies.

Authors:  Carolina T Orozco; Manuela Bersellini; Lorraine M Irving; Wesley W Howard; David Hargreaves; Paul W A Devine; Elise Siouve; Gareth J Browne; Nicholas J Bond; Jonathan J Phillips; Peter Ravn; Sophie E Jackson
Journal:  MAbs       Date:  2022 Jan-Dec       Impact factor: 6.440

9.  Structure and biophysical characterization of the human full-length neurturin-GFRa2 complex: A role for heparan sulfate in signaling.

Authors:  Jenny Sandmark; Göran Dahl; Linda Öster; Bingze Xu; Patrik Johansson; Tomas Akerud; Anna Aagaard; Pia Davidsson; Janna M Bigalke; Maria Sörhede Winzell; G Jonah Rainey; Robert G Roth
Journal:  J Biol Chem       Date:  2018-02-02       Impact factor: 5.157

10.  Engineering of Chinese Hamster Ovary Cells With NDPK-A to Enhance DNA Nuclear Delivery Combined With EBNA1 Plasmid Maintenance Gives Improved Exogenous Transient Reporter, mAb and SARS-CoV-2 Spike Protein Expression.

Authors:  James D Budge; Robert J Young; Christopher Mark Smales
Journal:  Front Bioeng Biotechnol       Date:  2021-06-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.